FindTrial
Sign In

Application of Platelet-rich plasma in the treatment of refractory wounds

Application of Platelet-rich plasma in the treatment of refractory wounds

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-ICR-15006924
Enrollment
Unknown
Registered
2015-08-10
Start date
2015-08-17
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

refractory wounds

Interventions

1:PRP coating after debridement
2:debridement

Sponsors

The First Affiliated Hospital of Chinese PLA General Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Aged 18 or more,Male or female; 2. Patients with soft tissue injury does not heal for more than four weeks.

Exclusion criteria

Exclusion criteria: 1. patients with hematological system diseases; 2. Patients treated with glucocorticoid for other disease; 3. Patients treated with immunosuppressive agents; 4. Drug addicts or heavy drinkers; 5. Patients who can not provide prior informed consent or delayed informed consent.

Design outcomes

Primary

MeasureTime frame
healing rate of wound;—

Secondary

MeasureTime frame
VEGF;TGF-beta;EGF;vimentin;alpha-SMA;—

Contacts

Public ContactDaifeng Hao
hdf304@126.com+86 13910036778

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026